Woodline Partners LP 13D and 13G filings for Quoin Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 09:13 am Unchanged | 2026-03-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Woodline Partners LP | 2,785,370 4.400% | 0 (Unchanged) | Filing |
| 2026-02-17 3:20 pm Purchase | 2025-12-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Woodline Partners LP | 2,785,370 9.500% | 2,785,370 (New Position) | Filing |